Aurinia Pharmaceuticals Inc XNAS: AUPH

Strong Performer, Getting Expensive

Download real time

15.50 0.01 (0.06%)

Near 52W High of $16.20

1.9M

XNAS Volume

XNAS 18 Nov, 2025 4:30 PM (EST)

Aurinia Pharmaceuticals Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents